SEC Form 4 · accession 0001140361-15-010833
Relypsa Inc · RLYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claire Lockey
Officer — See Remarks
Period of report
Mar 4, 2015
Accepted (ET)
Mar 6, 2015 · 7:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416792
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 4, 2015 | M | 9,052 | $4.65 | A | 14,552 | D | |
| Common StockF1 | Mar 4, 2015 | M | 948 | $3.79 | A | 15,500 | D | |
| Common StockF1 | Mar 4, 2015 | S | 10,000 | $40.00 | D | 5,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $4.65 | Mar 4, 2015 | M | 9,052 | D | — | Sep 28, 2020 | Common Stock | 9,052 | 215 | D |
| Stock Option (right to buy)F3 | $3.79 | Mar 4, 2015 | M | 948 | D | — | May 24, 2020 | Common Stock | 948 | 25,214 | D |
Explanation of responses
- F1Includes 5,500 restricted stock units.
- F2The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- F3100% of the shares subject to the option are fully vested and exercisable.
Remarks
SVP, Pharmaceutical Development and Regulatory Affairs